|

Development of a Digital Personalised Nutrition Tool for Adolescents Undergoing Cancer Treatment

RECRUITINGN/ASponsored by KU Leuven
Actively Recruiting
PhaseN/A
SponsorKU Leuven
Started2026-09
Est. completion2029-03
Eligibility
Age12 Years – 18 Years
Healthy vol.Accepted

Summary

This study aims to develop and test MybYte, a smartphone tool designed to support personalised nutrition for teenagers aged 12-18 undergoing cancer treatment. MybYte will ask short questions about eating, appetite and treatment-related symptoms and provide personalised nutrition advice developed by healthcare professionals. In Phase 1, around 15 teenagers will help co-design and refine the tool through interviews and feedback. In Phase 2, around 15 newly diagnosed teenagers will use MybYte for one week each month over six months, alongside routine assessments of nutrition, body composition, taste, energy needs and quality of life. The study will assess whether MybYte is acceptable, practical and helpful for teenagers receiving cancer treatment.

Eligibility

Age: 12 Years – 18 YearsHealthy volunteers accepted
Inclusion Criteria

* Written informed consent has been obtained from a parent/legal guardian.
* Written assent has been obtained from participants.
* Aged between 12 and 18 years at the time of enrolment.
* Ability to use a smartphone independently.
* Adequate cognitive capacity to participate in study procedures, as determined by the research team.
* Proficiency in Dutch
* For Phase 1:
* Currently receiving, or having previously received cancer treatment (including chemotherapy) at University Hospitals Leuven within the specified age range.
* For Phase 2:
* New histological diagnosis of cancer
* Enrolled into the study within 6 weeks of diagnosis.
* Currently receiving cancer treatment (including chemotherapy) at University Hospitals Leuven.

Exclusion Criteria Phase 1 and 2:

* Presence of cognitive, developmental, or neurological impairments that compromise the ability to provide informed consent or assent, or that impair \\ independent use of a digital tool
* Medical instability or clinical condition deemed too unwell for participation, as determined by the treating clinician.
* Admitted to the intensive care unit during the enrollment period.
* Currently on a palliative care trajectory.

Conditions3

CancerMalnutrition in ChildrenPaediatric Oncology

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.